Welcome!

News Feed Item

Everyday Health Reports Second Quarter 2014 Financial Results

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Everyday Health, Inc. (NYSE: EVDY), a leading digital health and wellness company, today announced financial results for the second quarter ended June 30, 2014.  

Everyday Health, Inc. Logo.
  • Advertising and sponsorship revenue grew 16% year-over-year.
  • Average revenue per advertiser increased 39% year-over-year.
  • Mobile revenue grew 60% year-over-year.
  • Adjusted EBITDA grew 72% year-over-year.
  • Non-GAAP EPS was $0.07.

"We are extremely pleased with our performance in the second quarter of 2014, as we continue to provide market-leading solutions and real results for our customers, consumers, and healthcare professionals," said Ben Wolin, Co-Founder and CEO of Everyday Health. "Our new consumer and professional partnerships with influential constituents across the healthcare ecosystem further validate our unique business model and will strengthen our leadership position in the marketplace."

Financial Highlights

For the three months ended June 30, 2014:

  • Total revenue was $41.4 million, an 11% increase from $37.2 million in the prior year period. 
    • Advertising and sponsorship revenue was $36.9 million, a 16% increase from $31.8 million in the prior year period.
    • Premium services revenue was $4.6 million, a 15% decrease from $5.4 million in the prior year period, consistent with the Company's strategy of focusing on advertising and sponsorship revenue.
  • Adjusted EBITDA was $6.9 million, a 72% increase from $4.0 million in the prior year period.
  • Net income on a non-GAAP basis was $2.4 million, compared to a loss of ($2.9) million in the prior year period. Earnings per share on a non-GAAP diluted basis was $0.07. Net loss on a GAAP basis was ($0.6) million, before the impact of the non-cash, one-time deemed dividend of $8.1 million associated with the conversion of the Company's Series G preferred stock at the time of its initial public offering, compared to a net loss of ($6.2) million in the prior year period. Net loss per share on a GAAP basis was ($0.02) before the Series G deemed dividend, or ($0.29) including the impact of the Series G deemed dividend. A description of the non-GAAP calculations and reconciliation to comparable GAAP measures is provided in the accompanying tables entitled "Adjusted EBITDA Reconciliation" and "Reconciliation of Non-GAAP Net Income (Loss)."

"Our continued ability to deliver profitable growth validates the success of our strategy to go deeper with our existing customers and to leverage our partnership business model," said Brian Cooper, CFO of Everyday Health. "We are pleased with our performance and excited about our opportunity in the second half of 2014."

Business Highlights

The Company has also entered into several key business partnerships across its consumer and professional businesses, including the following:

  • An extension of the Company's long-standing relationship with Mayo Clinic, through which the Company will deliver Mayo Clinic's educational content, resources, and tools on MedPage Today.
  • The "Diabetes Step-by-Step" initiative, a highly engaging multimedia consumer resource for diabetes education and support, which will feature Randy Jackson, the popular television personality and diabetes advocate.
  • A partnership with the American Society of Clinical Oncology ("ASCO") to provide editorial coverage of ASCO's numerous conferences and a digital channel to communicate directly with their physicians. With this partnership, Everyday Health will reach approximately 90% of all oncologists and hematologists in the U.S.
  • A collaboration with SERMO, the leading social network for physicians, to provide MedPage Today content to the SERMO physician audience and to offer MedPage Today's custom marketing programs on the SERMO network.

Financial Outlook

For the third quarter of 2014 and full year 2014, the Company anticipates achieving financial results as set forth below:

Third Quarter of 2014



Total Revenue

$41.4 million – $42.2 million


Advertising & Sponsorship Revenue

$37.0 million – $37.8 million


Adjusted EBITDA

$6.75 million – $6.85 million




Full Year 2014



Total Revenue

$180.2 million – $181.8 million


Advertising & Sponsorship Revenue

$162.0 million – $164.0 million


Adjusted EBITDA

$34.2 million – $34.7 million

Earnings Teleconference Information

The Company will discuss its second quarter 2014 financial results and business outlook during a teleconference today, August 11, 2014, at 5:00 PM ET.  The conference call can be accessed at (877) 201-0168 or (647) 788-4901 (International), conference ID# 76415896. The call will also be broadcast simultaneously at http://ir.everydayhealth.com.

Following completion of the call, a recorded replay of the webcast will be available on Everyday Health's website.  To listen to the telephone replay, call toll-free (855) 859-2056 or (404) 537-3406 (International), conference ID# 76415896. The telephone replay will be available from 8:00 PM ET August 11 through 11:59 PM ET August 17, 2014. Additional investor information can be accessed at http://ir.everydayhealth.com.

About Everyday Health, Inc.  

Everyday Health, Inc. (NYSE: EVDY) is a leading provider of digital health and wellness solutions. Everyday Health attracts a large and engaged audience of consumers and healthcare professionals to its premier health and wellness properties, and utilizes its data and analytics expertise to deliver highly personalized content experiences and efficient and effective marketing and engagement solutions. Everyday Health enables consumers to manage their daily health and wellness needs, healthcare professionals to stay informed and make better decisions for their patients, and marketers, health payors and providers to communicate and engage with consumers and healthcare professionals to drive better health outcomes. Everyday Health's content and solutions are delivered through multiple channels, including desktop, mobile web, and mobile phone and tablet applications, as well as video and social media.

Safe Harbor Provision

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by their use of terms and phrases such as "anticipate," "enable," "expect," "will," "believe," "continue" and other similar terms and phrases, and such forward-looking statements include, but are not limited to, the statements regarding our future financial performance set forth under the heading "Financial Outlook." The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: our ability to attract and retain users to our portfolio of properties; our ability to attract and retain customers; the timing and amount of advertising spending by our current and future customers; our ability to enter into new, or extend existing, partnership arrangements; our ability to successfully pursue opportunities in the broader health and wellness sectors; as well as those factors contained in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 filed with the SEC on May 13, 2014 and our other SEC filings. All information in this release is as of August 11, 2014. Except as required by law, we undertake no obligation to update publicly any forward-looking statement made herein for any reason to conform the statement to actual results or changes in our expectations.

Use of Non-GAAP Financial Measures

To supplement the financial measures presented in the Company's press release and related conference call or webcast in accordance with accounting principles generally accepted in the United States ("GAAP"), we also present the following non-GAAP measures of financial performance: Adjusted EBITDA, non-GAAP net income (loss) and non-GAAP earnings per share ("EPS").

A "non-GAAP financial measure" refers to a numerical measure of the Company's historical or future financial performance, financial position, or cash flows that excludes (or includes) amounts that are included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP in the Company's financial statements. The Company provides certain non-GAAP measures as additional information relating to its operating results as a complement to results provided in accordance with GAAP. The non-GAAP financial information presented here should be considered in conjunction with, and not as a substitute for or superior to, the financial information presented in accordance with GAAP and should not be considered a measure of the Company's liquidity. There are significant limitations associated with the use of non-GAAP financial measures. Further, these measures may differ from the non-GAAP information, even where similarly titled, used by other companies and therefore should not be used to compare the Company's performance to that of other companies.

The Company has presented Adjusted EBITDA, non-GAAP net income (loss) and non-GAAP EPS as non-GAAP financial measures in this press release. We define Adjusted EBITDA as net loss plus: interest expense, net; income tax expense; depreciation and amortization expense; stock-based compensation expense; compensation expense related to acquisition earnout arrangements; write-offs of unamortized deferred financing and other debt extinguishment costs; reduction in force severance charges; loss from discontinued operations; and certain other non-cash charges such as preferred stock warrant mark-to-market adjustments. We define non-GAAP net income (loss) as net loss, plus non-cash stock-based compensation, non-cash deemed dividend on the Series G IPO ratchet, compensation expense related to acquisition earnout arrangements, loss from discontinued operations, and other unusual or significant adjustments such as the write-off of deferred finance costs and other debt extinguishment costs and the preferred stock mark-to-market adjustment. We define non-GAAP EPS as non-GAAP net income (loss) divided by weighted-average shares outstanding, which reflects the issuance of the shares sold in the IPO, as well as the conversion of all outstanding shares of preferred stock into common stock in connection with the Company's IPO, which closed on April 2, 2014.

The Company believes the use of non-GAAP financial measures, as a supplement to GAAP measures, is useful to investors in that they eliminate items that are either not part of the Company's core operations or do not require a cash outlay, such as stock-based compensation. Our management uses these non-GAAP financial measures when evaluating the Company's operating performance and for internal planning and forecasting purposes. The Company believes that these non-GAAP financial measures help indicate underlying trends in the Company's business, are important in comparing current results with prior period results, and are useful to investors and financial analysts in assessing the Company's operating performance.

 

EVERYDAY HEALTH, INC.


Consolidated Balance Sheets


(in thousands, except share and per share data)










June 30,
2014
 (unaudited)


December 31,
2013



Assets








Current assets:








Cash and cash equivalents


$

55,084


$

16,242


Accounts receivable, net of allowance for doubtful accounts of $487 and $530 as of June 30, 2014 and December 31, 2013, respectively



39,635



49,373


Deferred tax asset



133



133


Prepaid expenses and other current assets



7,193



7,822


Total current assets



102,045



73,570


Property and equipment, net



22,839



21,095


Goodwill



82,153



82,153


Intangible assets, net



8,644



9,735


Other assets



4,806



5,729


Total assets


$

220,487


$

192,282










Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)








Current liabilities:








Accounts payable


$

7,108


$

8,459


Accrued expenses



14,609



25,919


Deferred revenue



8,156



6,808


Current portion of long-term debt



2,000



1,333


Other current liabilities



854



830


Total current liabilities



32,727



43,349


Long-term debt



38,000



70,000


Deferred tax liabilities



5,680



5,199


Other long-term liabilities



4,340



4,937


Redeemable convertible preferred stock (Series A-G), net of expenses, $0.01 par value: 10,000,000 and 27,204,144 shares authorized at June 30, 2014 and December 31, 2013, respectively; no shares and 26,820,270 shares issued and outstanding at  June 30, 2014 and December 31, 2013, respectively



-



158,766


Stockholders' equity (deficit):








Common stock, $0.01 par value: 90,000,000 and 45,000,000 shares authorized at June 30, 2014 and December 31, 2013, respectively; 30,185,974 and 5,366,478 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively



302



54


Treasury stock



(55)



(55)


Additional paid-in capital



279,620



33,726


Accumulated deficit



(140,127)



(123,694)


Total stockholders' equity (deficit)



139,740



(89,969)


Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)


$

220,487


$

192,282


 

EVERYDAY HEALTH, INC.

Consolidated Statements of Operations

(in thousands, except share and per share data, unaudited)
















Three months ended June 30,


Six months ended June 30,



2014


2013


2014


2013

Revenues













Advertising and sponsorship revenues 


$

36,882


$

31,819


$

69,574


$

57,199

Premium services revenues 



4,565



5,379



9,378



10,503

Total revenues 



41,447



37,198



78,952



67,702

Operating expenses:













Cost of revenues



10,961



10,826



22,382



20,661

Sales and marketing



13,069



11,860



24,039



20,921

Product development



9,952



10,700



19,964



20,860

General and administrative



7,126



6,191



13,721



12,730

Total operating expenses



41,108



39,577



80,106



75,172

Income (loss) from operations



339



(2,379)



(1,154)



(7,470)

Interest expense, net



(585)



(2,015)



(2,448)



(4,144)

Other expense



-



-



(4,114)



-

Loss from continuing operations before provision for income taxes 



(246)



(4,394)



(7,716)



(11,614)

Provision for income taxes 



(349)



(247)



(638)



(511)

Loss from continuing operations



(595)



(4,641)



(8,354)



(12,125)

Loss from discontinued operations, net of tax



-



(1,596)



-



(3,341)

Net loss



(595)



(6,237)



(8,354)



(15,466)

Series G preferred stock deemed dividend



(8,079)



-



(8,079)



-

Net loss attributable to common stockholders


$

(8,674)


$

(6,237)


$

(16,433)


$

(15,466)














Net loss from continuing operations per share—basic and diluted


$

(0.02)


$

(0.92)


$

(0.47)


$

(2.44)

Net loss from discontinued operations per share—basic and diluted


$

-


$

(0.32)


$

-


$

(0.67)














Net loss per share—basic and diluted


$

(0.02)


$

(1.24)


$

(0.47)


$

(3.11)














Net loss attributable to common stockholders per share—basic and diluted


$

(0.29)


$

(1.24)


$

(0.93)


$

(3.11)














Weighted-average common shares outstanding—basic and diluted



29,802,970



5,030,265



17,670,809



4,978,075

 










EVERYDAY HEALTH, INC.


Consolidated Statements of Cash Flows


(in thousands, unaudited)




Six months ended June 30,



2014


2013

Cash flows from operating activities








Net loss 


$

(8,354)


$

(15,466)


Less loss from discontinued operations, net of tax 



-



3,341


Loss from continuing operations 



(8,354)



(12,125)


Adjustments to reconcile loss from continuing operations to net cash provided
   by operating activities:








Depreciation and amortization 



7,150



7,817


Amortization of video and television costs 



-



449


Provision for doubtful accounts 



215



62


Stock-based compensation 



4,019



969


Amortization and write-off of financing costs 



4,239



823


Loss on disposals of property and equipment



-



147


Provision for deferred income taxes 



481



481


Changes in operating assets and liabilities:








Accounts receivable 



9,522



5,741


Prepaid expenses and other current assets 



(456)



(334)


Additions to video and television costs  



-



(423)


Accounts payable and accrued expenses 



(11,740)



(1,333)


Deferred revenue 



1,347



1,943


Other current liabilities 



(103)



(331)


Other long-term liabilities 



618



631


Net cash provided by operating activities from continuing operations 



6,938



4,517


Net cash used in operating activities from discontinued operations 



-



(3,504)


Net cash provided by operating activities 



6,938



1,013


Cash flows from investing activities








Additions to property and equipment, net 



(7,441)



(5,438)


Proceeds from sale of business 



400



-


Payment for business purchased, net of cash acquired 



-



(4,304)


Payment of security deposits and other assets 



47



(755)


Net cash used in investing activities 



(6,994)



(10,497)


Cash flows from financing activities








Net proceeds from common stock issuance



70,622



-


Proceeds from the exercise of stock options 



2,151



31


Repayments of principal under former revolver credit facility



(30,000)



(400)


Repayment of principal under former term loan facility 



(41,333)



(1,417)


Borrowings under revolver credit facility



32,300



-


Repayment of principal under revolver credit facility



(32,300)



-


Borrowings under term loan facility 



40,000



-


Principal payments on capital lease obligations 



(308)



(156)


Payments of credit facility financing costs 



(2,234)



-


Payment for purchase of treasury stock 



-



(55)


Net cash provided by (used in) financing activities



38,898



(1,997)


Net decrease in cash and cash equivalents 



38,842



(11,481)


Cash and cash equivalents, beginning of period



16,242



23,888


Cash and cash equivalents, end of period


$

55,084


$

12,407


Supplemental disclosure of cash flow information








Interest paid 


$

2,867


$

3,229


Income taxes paid 


$

163


$

37


Supplemental disclosure of non-cash investing and financing activities








Issuance of common stock for acquired business 


$

919


$

1,814


Issuance of common stock for acquired assets


$

-


$

74


Warrants issued in connection with website partner agreement


$

1,131


$

-


Capital lease obligations incurred


$

362


$

344


Reclassification of liability warrants to equity warrants


$

1,140


$

-









 















EVERYDAY HEALTH, INC.


Adjusted EBITDA Reconciliation


(in thousands, unaudited)
















Three months ended June 30,


Six months ended June 30,



2014



2013



2014



2013

Adjusted EBITDA

$

6,932


$

4,030


$

10,149


$

4,196















       Interest Expense, net


585



2,015



2,448



4,144


       Income tax provision


349



247



638



511


       Depreciation and amortization expense


3,592



3,897



7,150



7,817


       Stock compensation expense


2,950



517



4,019



969


       Compensation expense related to acquisition earnout


51



1,175



135



1,375


       Write-off of debt extinguishment costs


-



-



3,861



-


       Reduction in force severance charges


-



673



-



1,358


       Preferred stock warrant mark-to-market adjustment


-



-



252



-


       Asset impairment charges


-



147



-



147


       Loss from discontinued operations


-



1,596



-



3,341


Net loss

$

(595)


$

(6,237)


$

(8,354)


$

(15,466)















       Deemed Dividend on Series G Ratchet Provision


8,079



-



8,079



-


Net loss attributable to common stockholders

$

(8,674)


$

(6,237)


$

(16,433)


$

(15,466)














 















EVERYDAY HEALTH, INC.


Reconciliation of Non-GAAP Net Income (Loss)


(in thousands, except share and per share data, unaudited)

















Three months ended June 30,



Six months ended June 30,



2014



2013



2014



2013


Net loss attributable to common stockholders

$

(8,674)


$

(6,237)


$

(16,433)


$

(15,466)















       Deemed Dividend on Series G Ratchet Provision


8,079



-



8,079



-


       Stock compensation expense


2,950



517



4,019



969


       Write-off of debt extinguishment costs


-



-



3,861



-


       Preferred stock warrant mark-to-market adjustment


-



-



252



-


       Compensation expense related to acquisition earnout


51



1,175



135



1,375


       Loss from discontinued operations


-



1,596



-



3,341















Non-GAAP net income (loss)

$

2,406


$

(2,949)


$

(87)


$

(9,781)















Weighted-average common shares outstanding—basic


29,802,970



5,030,265



17,670,809



4,978,075


Weighted-average common shares outstanding—diluted


32,663,419



5,030,265



17,670,809



4,978,075















Non-GAAP net income (loss) per common share—basic

$

0.08


$

(0.59)


$

(0.00)


$

(1.96)


Non-GAAP net income (loss) per common share—diluted

$

0.07


$

(0.59)


$

(0.00)


$

(1.96)



























 

Logo - http://photos.prnewswire.com/prnh/20101112/NY00568LOGO

SOURCE Everyday Health, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discussed how a new approach is neces...
"With Digital Experience Monitoring what used to be a simple visit to a web page has exploded into app on phones, data from social media feeds, competitive benchmarking - these are all components that are only available because of some type of digital asset," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
What's the role of an IT self-service portal when you get to continuous delivery and Infrastructure as Code? This general session showed how to create the continuous delivery culture and eight accelerators for leading the change. Don Demcsak is a DevOps and Cloud Native Modernization Principal for Dell EMC based out of New Jersey. He is a former, long time, Microsoft Most Valuable Professional, specializing in building and architecting Application Delivery Pipelines for hybrid legacy, and cloud ...
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"We were founded in 2003 and the way we were founded was about good backup and good disaster recovery for our clients, and for the last 20 years we've been pretty consistent with that," noted Marc Malafronte, Territory Manager at StorageCraft, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We view the cloud not as a specific technology but as a way of doing business and that way of doing business is transforming the way software, infrastructure and services are being delivered to business," explained Matthew Rosen, CEO and Director at Fusion, in this SYS-CON.tv interview at 18th Cloud Expo (http://www.CloudComputingExpo.com), held June 7-9 at the Javits Center in New York City, NY.
The Founder of NostaLab and a member of the Google Health Advisory Board, John is a unique combination of strategic thinker, marketer and entrepreneur. His career was built on the "science of advertising" combining strategy, creativity and marketing for industry-leading results. Combined with his ability to communicate complicated scientific concepts in a way that consumers and scientists alike can appreciate, John is a sought-after speaker for conferences on the forefront of healthcare science,...
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, introduced two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a multip...
"Software-defined storage is a big problem in this industry because so many people have different definitions as they see fit to use it," stated Peter McCallum, VP of Datacenter Solutions at FalconStor Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: implemen...
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
In his session at Cloud Expo, Alan Winters, U.S. Head of Business Development at MobiDev, presented a success story of an entrepreneur who has both suffered through and benefited from offshore development across multiple businesses: The smart choice, or how to select the right offshore development partner Warning signs, or how to minimize chances of making the wrong choice Collaboration, or how to establish the most effective work processes Budget control, or how to maximize project result...
"DivvyCloud as a company set out to help customers automate solutions to the most common cloud problems," noted Jeremy Snyder, VP of Business Development at DivvyCloud, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
CI/CD is conceptually straightforward, yet often technically intricate to implement since it requires time and opportunities to develop intimate understanding on not only DevOps processes and operations, but likely product integrations with multiple platforms. This session intends to bridge the gap by offering an intense learning experience while witnessing the processes and operations to build from zero to a simple, yet functional CI/CD pipeline integrated with Jenkins, Github, Docker and Azure...